Skip to main content
SpringerLink
Log in

Use of Phosphatidylcholine in Brain Diseases: An Overview

  • Chapter
Lecithin

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 33))

Abstract

Two biochemical effects of phosphatidylcholine (PC) account for its use in clinical trials treating brain diseases: PC as a precursor for acetylcholine (ACh) biosynthesis, and PC as an integral part of neuronal membranes. This chapter reviews the scientific basis for each postulated use, and describes the results of PC administration to patients with neurological and psychiatric diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alarcon, R.D., Tolbert, L.C., Monti, J.A., Morere, D.A., Walter-Ryan, W.G., Kemp, B., Smythies, J.R., 1985, One-carbon metabolism disturbances in affective disorders. A preliminary report, J. Affective Disord., 9:297–301.

    Article  CAS  Google Scholar 

  2. Ailing, C., Gustavsson, L., Kristensson-Aas, A., Wallerstedt, S., 1984, Changes in fatty acid composition of major glycerophospholipids in erythrocyte membranes from chronic alcoholics during withdrawal, Scand. J. Clin. Lab. Invest., 44:283–289.

    Article  Google Scholar 

  3. Ansell, G.B., 1981, The biochemical background to tardive dyskinesia, Neuropharmacology, 4:311–317.

    Article  Google Scholar 

  4. Ansell, G.B., Spanner, S., 1978, The source of choline for acetylcholine synthesis, in: “Cholinergic Mechanisms and Psychopharmacology”, D.J. Jenden, ed., Plenum, New York, pp.431–445.

    Chapter  Google Scholar 

  5. Aquilonius, S.M., Eckernas, S.A., 1977, Choline therapy in Huntington’s chorea, Neurology, 27:887–889.

    Article  PubMed  CAS  Google Scholar 

  6. Baldessarini, R.J., Tarsy, D., 1980, Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs, Ann. Rev. Neurosci., 3:23–41.

    Article  PubMed  CAS  Google Scholar 

  7. Barany, M., Chang, Y.C., Arus, C., Rustan, T., Frey, W.H.II, 1985, Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer’s brain, Lancet i, 517.

    Article  Google Scholar 

  8. Barbeau, A., 1978, Emerging treatments: replacement therapy with choline or lecithin in neurological diseases, Can. J. Neurol. Sci., 1:157–160.

    Google Scholar 

  9. Barbeau, A., 1979, Lecithin in movement disorders, in.: “Choline and Lecithin in Brain Disorders”, vol. 5, Nutrition and the Brain, A. Barbeau, J.H. Growdon, R.J. Wurtman, eds., Raven Press, New York, pp. 263–271.

    Google Scholar 

  10. Barbeau, A., 1980, Lecithin in Parkinson’s disease, J. Neurol. Transm., 16:187–193.

    Google Scholar 

  11. Barbeau, A., 1980, Cholinergic treatment in the Tourette syndrome, N. Engl. J. Med., 302:1310–1311.

    Article  PubMed  CAS  Google Scholar 

  12. Barbeau, A., Butterworth, R.F., Ngo, T., et al., 1976, Pyruvate metabolism in Friedreich’s ataxia, Can. J. Neurol. Sci., 3:379–388.

    PubMed  CAS  Google Scholar 

  13. Barenholz, Y., Yechiel, E., Cohen, R., Deckelbaum, R.J., 1981, Importance of cholesterol-phospholipid interaction in determining dynamics of normal and abetalipoproteinemia red blood cell membrane, Cell Biophys., 3:115–126.

    PubMed  CAS  Google Scholar 

  14. Bartus, R.T., Dean, R.L., Goas, J.A., Lippa, A.S., 1980, Age-related changes in passive avoidance retention: modulation with dietary choline, Science, 209:301–303.

    Article  PubMed  CAS  Google Scholar 

  15. Bierkamper, G.G., Goldberg, A.M., 1980, Release of acetylcholine from the vascular perfused rat phrenic nerve-hemidiaphragm, Brain Res., 202:234–237.

    PubMed  CAS  Google Scholar 

  16. Bird, E.D., Iversen, L.L., 1974, Huntington’s chorea: post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia, Brain, 97:457–472.

    Article  PubMed  CAS  Google Scholar 

  17. Blusztajn, J.K., Wurtman, R.J., 1981, Choline biosynthesis by a preparation enriched in synaptosomes from rat brain, Nature, 290:417–418.

    Article  PubMed  CAS  Google Scholar 

  18. Blusztajn, J.K., Wurtman, R.J., 1983, Choline and cholinergic neurons, Science, 221:614–620.

    Article  PubMed  CAS  Google Scholar 

  19. Bondareff, W., Mountjoy, C.Q., Roth, M., 1982, Loss of neurons of origin of the adrenergic projection of cerebral cortex (nucleus locus coeruleus) in senile dementia, Neurology, 32:164–168.

    Article  PubMed  CAS  Google Scholar 

  20. Branchey, M.H., Branchey, L.B., Bark, N.M., Richardson, M.A., 1979, Lecithin in the treatment of tardive dyskinesia, Commun. Psychopharmacol., 3:303–307.

    PubMed  CAS  Google Scholar 

  21. Candy, J.M., Perry, R.H., Perry, E.H., Irving, D., Blessed, G., Fairbairn, A.D., Tomlinson, B.E., 1983, Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s diseases, J. Neurol. Sci., 59:277–289.

    Article  PubMed  CAS  Google Scholar 

  22. Chamberlain, S., Robinson, N., Walker, J., Smith, C., Benton, S., Kennard, C., Swash, M., Kilkenny, B., Bradbury, S., 1980, Effect of lecithin on disability and plasma free-choline levels in Friedreich’s ataxia, J. Neurol. Neurosurg. Psychiatry, 43:843–845.

    Article  PubMed  CAS  Google Scholar 

  23. Cohen, B.M., Lipinski, J.F., Altesman, R.I., 1982, Lecithin in the treatment of mania: double-blind, placebo-controlled trials, Am. J. Psychiatry, 139:1162–1164.

    PubMed  CAS  Google Scholar 

  24. Cohen, B.M., Miller, A.L., Lipinski, J.F., Pope, H.G., 1980, Lecithin in mania: a preliminary report. Am. J. Psychiatry, 137:242–243.

    PubMed  CAS  Google Scholar 

  25. Cohen, E.L., Wurtman, R.J., 1975, Brain acetylcholine: increase after systemic choline administration, Life Sci., 16:1095–1102.

    Article  PubMed  CAS  Google Scholar 

  26. Cohen E.L., Wurtman, R.J., 1976, Brain acetylcholine: control by dietary choline, Science, 191:561–562.

    Article  PubMed  CAS  Google Scholar 

  27. Corkin, S., 1981, Brain acetylcholine, aging, and Alzheimer’s disease: implications for treatment, Trends in Neuroscience, 4:287–290.

    Article  CAS  Google Scholar 

  28. Corkin, S., Davis, K., Growdon, J., Usdin, E., Wurtman, R., 1982, Alzheimer’s Disease: A Report of Progress in Research, Raven Press, New York.

    Google Scholar 

  29. Cornford, E.M., Braun, L.D., Oldendorf, W.H., 1978, Carrier mediated blood-brain barrier transport of choline and certain choline analogs, J. Neurochem., 30: 299–308.

    Article  PubMed  CAS  Google Scholar 

  30. Davis, K.L., Berger, P.A., Hollister, L.E., 1975, Choline for tardive dyskinesia, N. Engl. J. Med., 293:152.

    PubMed  CAS  Google Scholar 

  31. Davis, K.L., Hollister, L.E., Barchas, J.D., et al., 1976, Choline in tardive dyskinesia and Huntington’s disease, Life Sci., 19: 1507–1519.

    Article  PubMed  CAS  Google Scholar 

  32. Davis, K.L., Hollister, L.E., Berger, P.A., Barchas, J.D., 1975, Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation, Psychopharmacol. Commun., 1:533–543.

    PubMed  CAS  Google Scholar 

  33. Davis, J.M., 1975, Critique of single amine theories: evidence of a cholinergic influence in the major mental illnesses, Res. Publ. Assoc. Res. Ment. Dis., 54:333–346.

    CAS  Google Scholar 

  34. Domino, E.F., May, W.W., Demetriou, S., Mathews, B., Tait, S., Kovacic, B., 1985, Lack of clinically significant improvement of patients with tardive dyskinesia following phosphatidylcholine therapy, Biol. Psychiatry, 20:1189–1196.

    Article  PubMed  CAS  Google Scholar 

  35. Drachman, D.A., 1977, Memory and cognitive function in man: Does the cholinergic system have a specific role? Neurology, 27:783–790.

    Article  PubMed  CAS  Google Scholar 

  36. Fibiger, H.C., Lloyd, K.G., 1984, Neurobiological substrates of tardive dyskinesia: the GABA hypothesis, Trends in Neurosci., 7:462–464.

    Article  CAS  Google Scholar 

  37. Filla, A., Campanella, G., 1982, A six-month phosphatidylcholine trial in Friedreich’s ataxia, Can. J. Neurol. Sci., 9:147–150.

    PubMed  CAS  Google Scholar 

  38. Finocchiaro, G., DiDonato, S., Madonna, M., Fusi, R., Ladinsky, H., Consolo, S., 1985, An approach using lecithin treatment for olivopontocerebellar atrophies, Eur. Neurol., 24:414–421.

    Article  PubMed  CAS  Google Scholar 

  39. Food and Drug Administration Task Force, American College of Neuropsycho-pharmacology, 1973, Neurological syndromes associated with antipsychotic drug use: a special report, Arch. Gen. Psychiatry, 28:463–467.

    Article  Google Scholar 

  40. Friedman E., Sherman, K., Ferris, S.H., Reisberg, B., Bartus, R.T., Schenk, M.K., 1981, Clinical response to choline plus piracetam in senile dementia: relation to red cell choline levels, N. Engl. J. Med., 304:1490–1491.

    Article  PubMed  CAS  Google Scholar 

  41. Gelenberg, A.J., Doller-Wojcik, J.C., Growdon, J.H., 1979, Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study, Am. J. Psychiatry, 136:772–776.

    PubMed  CAS  Google Scholar 

  42. Gibson, G.E., Blass, J.P., 1976, Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia, J. Neurochem., 27:37–42.

    Article  PubMed  CAS  Google Scholar 

  43. Growdon, J.H., 1986, Phosphatidylcholine and tardive dyskinesia (letter), Biol. Psychiatry, 21:702–703.

    Article  PubMed  CAS  Google Scholar 

  44. Growdon, J.H., Cohen, E.L., Wurtman, R.J., 1977, Treatment of brain diseases with dietary precursors of neurotransmitters, Ann. Intern. Med., 86:337–339.

    Article  PubMed  CAS  Google Scholar 

  45. Growdon, J.H., Cohen, E.L., Wurtman, R.J., 1977, Effects of oral choline administration on serum and CSF choline levels in patients with Huntington’s disease, J. Neurochem., 28:229–231.

    Article  PubMed  CAS  Google Scholar 

  46. Growdon, J.H., Cohen, E.L., Wurtman, R.J., 1977, Huntington’s disease: clinical and chemical effects of choline administration, Ann. Neurol., 1:418–422.

    Article  PubMed  CAS  Google Scholar 

  47. Growdon, J.H., Corkin, S., 1979, Neurochemical approaches to the treatment of senile dementia, in.:“Psychopathology in the Aged”, J.O. Cole, J. Barrett, eds., Raven Press, New York, pp. 281–294.

    Google Scholar 

  48. Growdon, J.H., Corkin, S., in press, Cognitive impairments in Parkinson’s disease, in:“Parkinson’s Disease (Advances in Neurology series)”, M.D. Yahr, R.C. Duvoisin, eds., Raven Press, New York.

    Google Scholar 

  49. Growdon, J.H., Corkin, S., Huff, F.J., Rosen, T.J., 1986, Piracetam combined with lecithin in the treatment of Alzheimer’s disease, Neurobiol. Aging, 7:269–276.

    Article  PubMed  CAS  Google Scholar 

  50. Growdon, J.H., Gelenberg, A.J., Doller, J., Hirsch, M.J., Wurtman, R.J., 1978, Lecithin can suppress tardive dyskinesia. N. Engl. J. Med., 298:1029–1030.

    PubMed  CAS  Google Scholar 

  51. Growdon, J.H., Gibson, C.J., 1982, Dietary precursors of neurotransmitters: treatment strategies, in:“Current Neurology”, S.H. Appel, ed., Wiley and Sons, New York, pp. 117–144.

    Google Scholar 

  52. Growdon, J.H., Hirsch, M.J., Wurtman, R.J., Weiner, W., 1977, Oral choline administration to patients with tardive dyskinesia, N. Engl. J. Med., 297:524–527.

    Article  PubMed  CAS  Google Scholar 

  53. Growdon, J.H., Wheeler, S., Graham, H.N., 1984, Plasma choline responses to lecithin-enriched soup, Psychopharmacol. Bull., 20:603–606.

    PubMed  CAS  Google Scholar 

  54. Growdon, J.H., Wurtman, R.J., 1983, The future of cholinergic precursor treatment in Alzheimer’s disease, in:“Banbury Report 15: Biological Aspect of Alzheimer’s Disease”, L. Moran, ed., Banbury Center, Cold Spring Laboratory, pp. 451–459.

    Google Scholar 

  55. Haubrich, D.R., Wang, P.F.L., Clody, D.E., Wedeking, P.W., 1975, Increases in rat brain acetylcholine induced by choline or deanol, Life Sci., 17:975–980.

    Article  PubMed  CAS  Google Scholar 

  56. Hegner, D., 1980, Age dependence of molecular and functional changes in biological membrane properties, Mech. Aging Develop., 14:101–118.

    Article  CAS  Google Scholar 

  57. Hirata, F., Axelrod, J., 1978, Enzymatic methylation of phosphatidylethanolamine increases erythrocyte membrane fluidity, Nature, 275:219–220.

    Article  PubMed  CAS  Google Scholar 

  58. Hirata, F., Axelrod, J., 1980, Phospholipid methylation and biological signal transmission, Science, 209:1082–1090.

    Article  PubMed  CAS  Google Scholar 

  59. Hirsch, M.J., Growdon, J.H., Wurtman, R.J., 1977, Increase in hippocampal acetylcholine after choline administration, Brain Res., 125:383–385.

    Article  PubMed  CAS  Google Scholar 

  60. Hirsch, M.J., Wurtman, R.J., 1978, Lecithin comsumption elevates acetylcholine concentrations in rat brain and adrenal gland, Science, 207:223–225.

    Article  Google Scholar 

  61. Hitzemann, R., Hirschowitz, J., Garver, D., 1984, Membrane abnormalities in the psychoses and affective disorders, J. Psychiatr. Res., 18:319–326.

    Article  PubMed  CAS  Google Scholar 

  62. Hitzemann, R., Mark, C., Hirschowitz, J., Garver, D., 1985, Characteristics of pohspholipid methylation in human erythrocyte ghosts: relationship(s) to the psychoses and affective disorders, Biol. Psychiatry, 20:397–407.

    Article  PubMed  CAS  Google Scholar 

  63. Hornykiewicz, O., 1982, Brain neurotransmitter changes in Parkinson’s disease, in:“Movement Disorders”, C.D. Marsden, S. Fahn, eds., Butterworth Scientific, London, pp. 41–58.

    Google Scholar 

  64. Iida, H., Takashima, Y., Maeda, S., Sekiya, T., Kawade, M., Kawamura, M., Okano, Y., Nozawa, Y., 1984, Alterations in erythrocyte membrane lipids in abetalipoproteinemia: phospholipid and fatty acyl composition, Biochem. Med., 32:79–87.

    Article  PubMed  CAS  Google Scholar 

  65. Infante, J.P., 1986, Defective synthesis of polyunsaturated phosphatidylcholines as the primary lesion in Duchenne and murine dy muscular dystrophies, Med. Hypotheses, 19:113–116.

    Article  PubMed  CAS  Google Scholar 

  66. Ishi, T., 1966, Distribution of Alzheimer’s neurofibrillary changes in the brainstem and hypothalamus of senile dementia, Acta Neurol. Pathol, 6:181–187.

    Article  Google Scholar 

  67. Jackson, I.V., Nuttall, E.A., Ibe, I.O., Perez-Cruet, J., 1979, Treatment of tardive dyskinesia with lecithin, Am. J. Psychiatry, 136:1458–1460.

    PubMed  CAS  Google Scholar 

  68. Jenike, M.A., Albert, M.S., Heller, H., LoCastro, S., Günther, J., 1986, Combination therapy with lecithin and ergoloid mesylates for Alzheimer’s disease, J. Clin. Psychiatry, 47:249–251.

    PubMed  CAS  Google Scholar 

  69. Janowsky, D.S., El-Yousef, M.K., Davis, J.M., Hubbard, H., Sekerke, H.J., 1972, Cholinergic reversal of manic symptoms, Lancet, 1:1236–1237.

    Article  PubMed  CAS  Google Scholar 

  70. Janowsky, D.S., El-Yousef, K., Davis, J.M., Sekerke, H.J., 1973, Parasympathetic suppression of manic symptoms by physostigmine, Arch. Gen. Psychiatry, 28:542–547.

    Article  PubMed  CAS  Google Scholar 

  71. Jenden, D.J., Weiler, M.H., Gundersen, C.B., 1982, Choline availability and acetylcholine synthesis, in: “Alzheimer’s Disease: A Report of Progress in Research”, S. Corkin, K.L. Davis, J.H. Growdon, et al., eds., Raven Press, New York, pp. 315–326.

    Google Scholar 

  72. Jones, F.D., Mass, J.W., Dekirmenjian, H., et al., 1975, Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolites, Am. J. Psychiatry, 132:1141–1148.

    Google Scholar 

  73. Kane, J.M., Woerner, M., Borenstein, M., Wegner, J., Lieberman, J., 1986, Integrating incidence and prevalence of tardive dyskinesia, Psychopharmacol. Bull., 22:254–258.

    PubMed  CAS  Google Scholar 

  74. Kark, P.A., Blass, J., Spence, M.A., 1977, Physostigmine in familial ataxias, Neurology, 27:70–72.

    Article  PubMed  CAS  Google Scholar 

  75. Kaye, W.H., Sitaram, N., Weingartner, H., Ebert, M.H., Smallberg, S., Gillin, J.C., 1982, Modest facilitation on memory in dementia with combined lecithin and anticholinesterase treatment, Biol. Psychiatry, 17:275–280.

    PubMed  CAS  Google Scholar 

  76. Kelemen, J., Hedlund, W., Murray-Douglas, P., Munsat, T.L., 1982, Lecithin is not effective in amyotrophic lateral sclerosis, Neurology, 32:315–316.

    Article  PubMed  CAS  Google Scholar 

  77. Klawans, H.L., Jr., Rubovits, R., 1972, Central cholinergic-anticholinergic antagonism in Huntington’s chorea, Neurology, 22:107–112.

    Article  PubMed  Google Scholar 

  78. Kunze, D., Rustow, B., Kuksis, A., Myher, J.J., 1986, Acylation of lysophosphatidylcholine and glycerolphosphate and fatty acid pattern in phosphatidylcholine and ethanolamine in microsomes of normal and dystrophic human muscle, Acta Neurol. Scand., 73:125–130.

    Article  PubMed  CAS  Google Scholar 

  79. LaDroitte, P., Lamboeuf, Y., de Saint Blanquat, G., Bezaury, J.P., 1985, Sensitivity of individual erythrocyte membrane phospholipids to changes in fatty acid composition in chronic alcoholic patients, Alcoholism (NY), 9:135–137.

    Article  Google Scholar 

  80. Lawrence, G.M., Millac, P., Stout, G.S., et al., 1980, The use of choline chloride in ataxic disorders, J. Neurol. Neurosurg., Psychiatry, 43:452–545.

    Article  CAS  Google Scholar 

  81. Legg, N.J., 1978, Oral choline in cerebellar ataxia, Br. Med. J., 2:1403–1404.

    Article  PubMed  CAS  Google Scholar 

  82. Little, A., Levy, R., Chuaqui-Kidd, P., Hand, D., 1985, A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer’s disease, J. Neurol. Neurosurg., Psychiatry, 48:736–742.

    Article  CAS  Google Scholar 

  83. Livingstone, I.R., Mastaglia, F.L., 1979, Choline chloride in the treatment of ataxia, Br. Med. J., 2:939.

    Article  PubMed  CAS  Google Scholar 

  84. London, E.D., Coyle, J.T., 1978, Pharmacological augmentation of acetylcholine levels in kainate lesioned rat striatum, Biochem. Pharmacol., 27:2962–2965.

    Article  PubMed  CAS  Google Scholar 

  85. Maas, J.W., 1975, Biogenic amines and depression — biochemical and pharmacological separation of two types of depression, Arch. Gen. Psychiatry, 32:1357–1361.

    Article  PubMed  CAS  Google Scholar 

  86. Mann, D.M.A., Lincoln, J., Yates, P.D., et al., 1980, Changes in monoamine containing neurons of the human CNS in senile dementia, Brit. J. Psychiatry, 136:533–541.

    Article  CAS  Google Scholar 

  87. Martin, J.B., 1984, Huntington’s disease: new approaches to an old problem, Neurology, 34:1059–1072.

    Article  PubMed  CAS  Google Scholar 

  88. Miatto O., Gonzalez, R.G., Buonanno, F., Growdon, J.H., in press, In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer’s disease, Can. J. Neurol. Sci.

    Google Scholar 

  89. Mizumori, S.J.Y., Patterson, T.A., Sternberg, H., Rosenzweig, M.R., Bennett, E.L., Timiras, P.S., 1985, Effects of dietary choline on memory and brain chmistry in aged mice, Neurobiol. of Aging, 6:51–56.

    Article  CAS  Google Scholar 

  90. McGeer, P.L., McGeer, E.G., Fibiger, H.C., 1973, Choline acetylase and glutamic acid decarboxylase in Huntington’s chorea, Neurology, 23:912–917.

    Article  PubMed  CAS  Google Scholar 

  91. Moldofsky, H., Sandor, P., 1983, Lecithin in the treatmen of Gilles de la Tourette’s syndrome, Am. J. Psychiatry, 140:1627–1629.

    PubMed  CAS  Google Scholar 

  92. Newhouse, P., Bridenbaugh, R.H., 1981, Pharmacologic characterization and lecithin treatment of a patient with spontaneous oral-facial dyskinesia and dementia. Am. J. Psychiatry, 138:251–252.

    PubMed  CAS  Google Scholar 

  93. Papavasiliou, P.S., Rosal, V., 1979, Effects of choline in patients with levodopa-induced dyskinesia, in: “Choline and Lecithin in Brain Disorders”, A. Barbeau, J.H. Growdon, R.J. Wurtman, eds., Raven Press, New York, pp. 335–341.

    Google Scholar 

  94. Pentland, B., Martyn, C.N., Steer, C.R., Christie, J.E., 1981, Lecithin treatment in Friedreich’s ataxia, Br. Med. J. (Clin. Res.), 282:1197–1198.

    Article  CAS  Google Scholar 

  95. Perez-Cruet, J., Menendez, I., Alvarez-Ghersi, J., Falcon, J.R., Valderrabano, O., Castro-Urrutia, E.C., Ifarraguerri, C., Perez, L.L., 1981, Double-blind study of lecithin in the treatment of persistent tardive dyskinesia. Bol. Assoc. Med. PR, 73:531–537.

    CAS  Google Scholar 

  96. Perry, E.K., Tomlinson, B.E., Blessed, G., Bergmann, K., Gibson, P.M., Perry, R.H., 1978, Correlation of cholinergic abnormalities with senile plaques and mental scores in senile dementia, Brit. Med. J., 2:1457–1459.

    Article  PubMed  CAS  Google Scholar 

  97. Peters, B.H., Levin, H.S., 1979, Effects of physostigmine and lecithin on memory in Alzheimer’s disease, Ann. Neurol., 6:219–221.

    Article  PubMed  CAS  Google Scholar 

  98. Pettegrew, J.W., Minshew, N.J., Cohen, M.M., Kopp, S.J., Glonek, T., 1984, 31-P changes in Alzheimer’s and Huntington’s disease brain, Neurology, 34:281.

    Google Scholar 

  99. Pettegrew J.W., Minshew, N., Glonek, T., Kopp, S., Cohen, M., 1982, 31-P nuclear magnetic resonance analysis of Huntington and control brain, Neurology, 32:196.

    Article  Google Scholar 

  100. Pettegrew, J.W., Minshew, N.J., Diehl, J., Smith, T., Kopp, S.J., Glonek, T., 1983, Anatomical considerations for interpreting topical P-31 NMR, Lancet, ii, 913.

    Article  Google Scholar 

  101. Philcox, D.V., Kies, B., 1979, Choline in hereditary ataxia, Brit. Med. J., 2:613.

    Article  PubMed  CAS  Google Scholar 

  102. Pirozzolo, F.J., Hansch, E.C., Mortimer, J.A., Webster, D.D., Kuskowski, M.A., 1982, Dementia in Parkinson’s disease: a neuropsychological analysis, Brain and Cognition, 1:71–83.

    Article  PubMed  CAS  Google Scholar 

  103. Polinsky, R.J., Ebert, M.H., Caine, E.D., Ludlow, C., Bassich, C.J., 1980, Cholinergic treatment in the Tourette syndrome, N. Engl. J. Med., 302:1310.

    Article  PubMed  CAS  Google Scholar 

  104. Randels, P.M., Marco, L.A., Ford, D.I., Mitchell, R., Scholl, M., Plesnarski, J., 1984, Lithium and lecithin treatment in Alzheimer’s disease: a pilot study, Hillside J. Clin. Psychiatry, 6:139–147.

    PubMed  CAS  Google Scholar 

  105. Reding, M.J., Blass, J.P., Stern, P.H., et al., 1981, Lecithin in hereditary ataxia, Neurology, 31:363–364.

    Article  PubMed  CAS  Google Scholar 

  106. Richardson, M.A., Craig, T.J., Branchey, M.H., 1982, Intra-patient variability in the measurement of tardive dyskinesia, Psychopharmacology (Berlin), 76:269–272.

    Article  CAS  Google Scholar 

  107. Scheife, R.T., Growdon, J.H., 1982, Treating tardive dyskinesia, Seminars in Neurology, 2:305–315.

    Article  Google Scholar 

  108. Schildkraut, J.J., 1965, The catecholamine hypothesis of affective disorders: a review of supporting evidence, Am. J. Psychiatry, 122:509–522.

    PubMed  CAS  Google Scholar 

  109. Schildkraut, J.J., Orsulak, P.J., Schatzberg, A.F., et al., 1978, Toward a biochemical classification of depressive disorders, Part I, Arch. Gen. Psychiatry, 35:1427–1433.

    Article  PubMed  CAS  Google Scholar 

  110. Schreier, H.A., 1982, Mania responsive to lecithin in a 13-year-old girl, Am. J. Psychiatry, 139:108–110.

    PubMed  CAS  Google Scholar 

  111. Smith, R.C., Vroulis, G., Johnson, R., Morgan, R., 1984, Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer’s disease, Psychopharmacol. Bull., 20:542–545.

    PubMed  CAS  Google Scholar 

  112. Stahl, S.M., Berger, P.A., 1980, Cholinergic treatment in the Tourette syndrome, N. Engl. J. Med., 302:1311.

    Article  Google Scholar 

  113. Tamminga, C.A., Smith, R.C., Erickson, S.E., et al., 1977, Cholinergic influences in tardive dyskinesia, Am. J. Psychiatry, 134:769–774.

    PubMed  CAS  Google Scholar 

  114. Tanner, C.M., Goetz, C.G., Klawans, H.L., 1982, Cholinergic mechanisms in Tourette syndrome, Neurology, 32:1315–1317.

    Article  PubMed  CAS  Google Scholar 

  115. Terry, R.D., Peck, A., DeTeresa, R., Schechter, R, Horoupian, D.S., 1981, Some morphometric aspects of the brain in senile dementia of the Alzheimer type, Ann. Neurol., 10:184–192.

    CAS  Google Scholar 

  116. Thal, L.J., Fuld, P.A., Masur, D.M., Sharpless, N.S., 1983, Oral physostigmine and lecithin improve memory in Alzheimer’s disease, Ann. Neurol., 13:491–496.

    Article  PubMed  CAS  Google Scholar 

  117. Tweedy, J.R., Garcia, CA., 1982, Lecithin treatment of cognitively impaired Parkinson’s patients, Eur. J. Clin. Invest., 12:87–90.

    Article  PubMed  CAS  Google Scholar 

  118. Ulus, I.H., Hirsch, M.J., Wurtman, R.J., 1977, Trans-synaptic induction of adrenal tyrosine hydroxylase activity by choline: evidence that choline administration increases cholinergic transmission, Proc. Natl. Acad. Sci. USA., 74:798–800.

    Article  PubMed  CAS  Google Scholar 

  119. Wecker, L., Dettbarn, W.D., Schmidt, E.D., 1978, Choline administration: modification of the central actions of atropine, Science, 199:86–87.

    Article  PubMed  CAS  Google Scholar 

  120. Wettstein, A., 1983, No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease, Ann. Neurol., 13:210–212.

    Article  PubMed  CAS  Google Scholar 

  121. Whitehouse, P.J., Price, D.L., Coyle, J.T., DeLong, M.R., 1981, Alzheimer’s disease: evidence for selective loss of cholinergic neurons in the nucleus basalis, Ann. Neurol., 10:122–126.

    Article  PubMed  CAS  Google Scholar 

  122. Wilcock, G.K., Esiri, M.M., Bowen, D.M., Smith, C.C.T., 1982, Alzheimer’s disease: correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities, J. Neurol. Sci., 57:407–417.

    Article  PubMed  CAS  Google Scholar 

  123. Wurtman, R.J., Blusztajn, J.K., Maire, J.C., 1985, “Autocannibalism” of choline-containing membrane phospholipids in the pathogenesis of Alzheimer’s disease — a hypothesis, Neurochem. Int., 7:369–372.

    Article  PubMed  CAS  Google Scholar 

  124. Wurtman, R.J., Hirsch, M.J., Growdon, J.H., 1977, Lecithin consumption raises serum free choline levels, Lancet, 2:68–69.

    Article  PubMed  CAS  Google Scholar 

  125. Yackulic, C.F., Anderson, B.G., Reker, D., Webb, E., Volavka, J., 1982, The safety of lecithin diet supplementation in schizophrenic patients, Biol. Psychiatry, 17:1445–1448.

    PubMed  CAS  Google Scholar 

  126. Zeisel, S.H., Growdon, J.H., Wurtman, R.J., Magil, S.G., Logue, M., 1980, Normal plasma choline responses to ingested lecithin, Neurology, 30:1226–1229.

    Article  PubMed  CAS  Google Scholar 

  127. Zubenko, G.S., Cohen, B.M., Growdon, J.H., Corkin, S., 1984, Cell membrane abnormality in patients with Alzheimer’s disease, Lancet, 2:235.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, 02114, USA

    John H. Growdon

Authors
  1. John H. Growdon
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Loyola University Stritch School of Medicine, Chicago, Illinois, USA

    Israel Hanin

  2. Medical School, University of Birmingham, Birmingham, UK

    G. Brian Ansell

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer Science+Business Media New York

About this chapter

Cite this chapter

Growdon, J.H. (1987). Use of Phosphatidylcholine in Brain Diseases: An Overview. In: Hanin, I., Ansell, G.B. (eds) Lecithin. Advances in Behavioral Biology, vol 33. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1933-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1933-8_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1935-2

  • Online ISBN: 978-1-4757-1933-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation